期刊文献+

240例癫痫患儿丙戊酸钠的血药浓度监测 被引量:6

Serum Concentration of Valproate Sodium:Analysis of 240 Epileptic Children
原文传递
导出
摘要 目的:监测癫痫患儿丙戊酸钠的血药浓度.方法:采用荧光偏振免疫法测定240例癫痫患儿的血药浓度并分析结果.结果:癫痫患儿丙戊酸钠血药浓度<50μg·mL^-1 的有69例/次(占28.75%),在50~100μg·mL^-1 之间的有153例/次(占63.75%),>100μg·mL^-1的有18例/次(占7.50%).结论:患儿血药浓度个体差异大,丙戊酸钠血药浓度监测对临床合理用药有重要的指导作用,应根据血药浓度个体化用药. OBJECTIVE: To monitor the serum concentration of valproate sodium in epileptic children.METHODS: The serum concentration of valproate sodium in 240 epileptic children patients were determined by fluorescence polarization immunoassay and the determination results were analyzed .RESULTS:Of the total 240 cases, 69 (28.75%) were 〈 50μg · mL^-1, 153(63.75%) were with the range of 50--100μg·mL^-1 and 18(7.50% ) were 〉 100/μg · mL^-1 in serum concentration of valproate sodium.CONCLUSION: There are great individual differences among patients in serum concentration of valproate sodium .Monitoring of the serum concentration of valproate sodium is of great importance in guiding reasonable clinical drug use. It is advisable to adopt individualized administration scheme according to serum drug concentration.
出处 《中国药房》 CAS CSCD 北大核心 2007年第20期1561-1562,共2页 China Pharmacy
关键词 癫痫患儿 丙戊酸钠 血药浓度 监测 个体化给药 Epileptic children Valproate sodium Serum concentration Monitoring Individualized administration
  • 相关文献

参考文献5

二级参考文献29

  • 1陈锦珊,杜青云,黄惠丽.丙戊酸钠治疗小儿癫痫血药浓度监测与合理用药[J].中国医院药学杂志,2004,24(7):424-426. 被引量:32
  • 2王永刚,赵继宗,张懋植,王硕,张建国.围手术期应用丙戊酸钠防治神经外科手术后早期癫痫的临床研究[J].北京医学,2004,26(5):291-293. 被引量:7
  • 3刘福,张国元,吴功柱.丙戊酸钠治疗癫痫的血药浓度监测结果分析[J].四川医学,2005,26(1):86-87. 被引量:4
  • 4陈刚主.治疗药物监测[M].北京:人民军医出版社,1998.55.
  • 5Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience[J]. CNS Drugrs, 2002,16(10) :695-714.
  • 6Dreifuss FE, Santilli N, Langer DH, et al. Valproic acid hepatic fatalities:a retrospective review[J]. Neurology, 1987,37(3) :379-385.
  • 7Dreifuss FE, Langer DH, Molinr KA, et al, Valproic acid hepatic fatalities,Ⅱ : U.S experience since 1984 [J]. Neurology, 1989, 39 ( 2 Pt 1 ) :201-207.
  • 8Bryant AE 3rd, Dreifuss FE. Valproic acid hepatic fatalities, Ⅲ. U. S.experience since 1986[J] . Neurology, 1996,46(2) :465-469.
  • 9Konig SA, Schcnk M, Sick C, et al. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults [J]. Epilepsia, 1999,40(7):1036-1040.
  • 10Krahenbuhl S, Mang G, Kupferschmidt H, et al. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity[J]. Gut, 1995,37(1):140-143.

共引文献27

同被引文献39

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部